New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
CSL Limited
CSL.AX
Shape
US Flag

ASX

147B

Biotechnology

303.03AUD
Shape2.45 ( 0.82%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-12%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

3%

Quote Panel

Shape
Updated October 21, 2024
1W 0.61 % 1M 4.48 % 3M -1.27 % 1Y 29.72 %

Key Metrics

Shape
  • Market Cap

    146.73B


  • Shares Outstanding

    484.21M


  • Share in Float

    483.93M


  • Dividende

    3.97


  • Earning Date

    No Data


  • Price Target

    303.03


  • Average Volume

    634135


  • Beta

    0.325


  • Range

    228.65-313.55


  • Industry

    Biotechnology


  • Website

    https://www.csl.com.au


  • Sector

    Healthcare


Fundamentals

Shape

19.90x

P/E Ratio

6.54x

P/S Ratio

5.63x

P/B Ratio

0.6

Debt/Equity

18.0%

Net Margin

$8.2

EPS

How CSL.AX compares to sector?

P/E Ratio

Relative Strength

Shape

CSL.AX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$16B

Shape56%

2025-Revenue

$6.41

Shape175%

2025-EPS

$5B

Shape105%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.19

arrow
arrow

N/A

4
vs NA

Q2.20

arrow
arrow

+21%

2.86
vs 2.37

Q4.20

arrow
arrow

+37%

5.49
vs 4

Q2.21

arrow
arrow

-44%

1.61
vs 2.86

Q4.21

arrow
arrow

-4%

5.25
vs 5.49

Q2.22

arrow
arrow

-17%

1.33
vs 1.61

Q4.22

arrow
arrow

-4%

5.06
vs 5.25

Q2.23

arrow
arrow

+38%

1.84
vs 1.33

Q4.23

arrow
arrow

+19%

6.01
vs 5.06

Q2.24

arrow
arrow

+26%

2.32
vs 1.84

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.19

arrow
arrow

NA

7.1B  vs NA

Q2.20

arrow
arrow

+13%

6.4B  vs 5.7B

Q4.20

arrow
arrow

+11%

7.9B  vs 7.1B

Q2.21

arrow
arrow

-9%

5.9B  vs 6.4B

Q4.21

arrow
arrow

+4%

8.2B  vs 7.9B

Q2.22

arrow
arrow

+6%

6.2B  vs 5.9B

Q4.22

arrow
arrow

+30%

10.7B  vs 8.2B

Q2.23

arrow
arrow

+43%

8.9B  vs 6.2B

Q4.23

arrow
arrow

+15%

12.3B  vs 10.7B

Q2.24

arrow
arrow

+14%

10.1B  vs 8.9B

Return on EquityShape

status-upQoQ

Q4.20

arrow
arrow

+24%

0.24
vs 0.14

Q2.21

arrow
arrow

+7%

0.07
vs 0.24

Q4.21

arrow
arrow

+12%

0.12
vs 0.07

Q2.22

arrow
arrow

+3%

0.03
vs 0.12

Q4.22

arrow
arrow

+11%

0.11
vs 0.03

Q2.23

arrow
arrow

+4%

0.04
vs 0.11

Q4.23

arrow
arrow

+12%

0.12
vs 0.04

Q2.24

arrow
arrow

+4%

0.04
vs 0.12

Institutionnal OwnershipShape

status-upQoQ

Q4.16

arrow
arrow

2

2
vs 1

100%

Q2.17

arrow
arrow

1

1
vs NA

NA

Q1.23

arrow
arrow

1

1
vs NA

NA

Q2.23

arrow
arrow

1

1
vs 1

NA

Q3.23

arrow
arrow

1

1
vs 1

NA

Q4.23

arrow
arrow

1

1
vs 1

NA

Q1.24

arrow
arrow

1

1
vs 1

NA

Q2.24

arrow
arrow

2

2
vs 1

100%

Earnings Growth

Latest News